Lü Y - Search Results

1

[Analysis of resistance tendency of bloodstream-infecting pathogens in China].

Lü Y, Li Y, Xue F, Zhang XZ, Hu YJ, Jin YF, Chu YZ, Hu ZD, Zhao JH, Pan SY, Zhao WS, Hu BJ, Yu YS, Deng QL, Yang J, Li Y, Liu WE, Lü XJ, Yang YJ, Zhou L, Dong F, Fu WL, Xu XL, Pei FY, Yang B, Meng L, Ji P, Wang S. Lü Y, et al. Among authors: lu xj. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jun;36(6):411-9. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24103203 Chinese.

2

[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].

Xiao YH, Gao L, Li Y, Lü Y, Liu J, Liu Y. Xiao YH, et al. Among authors: lu y. Zhonghua Yi Xue Za Zhi. 2004 Nov 17;84(22):1867-71. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15631795 Chinese.

3

Dissemination of Multidrug-Resistant Shigella flexneri and Shigella sonnei with Class 1, Class 2, and Atypical Class 1 Integrons in China.

Kang H, Wang L, Li Y, Lu Y, Fan W, Bi R, Qian H, Gu B. Kang H, et al. Among authors: lu y. Microb Drug Resist. 2019 Dec;25(10):1465-1474. doi: 10.1089/mdr.2018.0229. Epub 2019 Aug 1. Microb Drug Resist. 2019. PMID: 31369341

4

[Study on the molecular epidemiology of bacterial infection in patients in cardiac surgical intensive care unit].

Gao L, Lü Y, Cui L, Sun L. Gao L, et al. Among authors: lu y. Zhonghua Yi Xue Za Zhi. 2015 Oct;95(40):3269-72. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26815345 Chinese.

5

Prevalence and characterization of class 1 integrons in multi-drug resistant Salmonella sp. from China in 2010.

Shen D, Xu Y, Pan S, Li Y, Lu Y, Xu T, Xia W, Liu G, Gu B. Shen D, et al. Among authors: lu y. J Chemother. 2015 Feb;27(1):57-60. doi: 10.1179/1973947814Y.0000000175. Epub 2014 Feb 18. J Chemother. 2015. PMID: 24548096 No abstract available.

6

Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers.

Lü Y, Kang ZS, Zhu Y, Zhang M, Liu Y, Zhang M, Li TY, Xiao YH. Lü Y, et al. Chin Med J (Engl). 2011 Jan;124(2):242-5. Chin Med J (Engl). 2011. PMID: 21362374 Clinical Trial.

7

Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers.

Lü Y, Kang ZS, Liu Y, Li TY, Xiao YH. Lü Y, et al. Chin Med J (Engl). 2007 Jan 20;120(2):166-8. Chin Med J (Engl). 2007. PMID: 17335665 Clinical Trial. No abstract available.

8

Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers.

Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Zhang M, Li T. Xiao Y, et al. Among authors: lu y. Biopharm Drug Dispos. 2008 Apr;29(3):167-72. doi: 10.1002/bdd.600. Biopharm Drug Dispos. 2008. PMID: 18240275 Clinical Trial.

9

Chemoresistance mechanisms of breast cancer and their countermeasures.

Ji X, Lu Y, Tian H, Meng X, Wei M, Cho WC. Ji X, et al. Among authors: lu y. Biomed Pharmacother. 2019 Jun;114:108800. doi: 10.1016/j.biopha.2019.108800. Epub 2019 Mar 25. Biomed Pharmacother. 2019. PMID: 30921705 Free article. Review.

10

Breast cancer treatment and sulfotransferase.

Ji XW, Zhou TY, Lu Y, Wei MJ, Lu W, Cho WC. Ji XW, et al. Among authors: lu y, lu w. Expert Opin Ther Targets. 2015 Jun;19(6):821-34. doi: 10.1517/14728222.2015.1014803. Epub 2015 Feb 12. Expert Opin Ther Targets. 2015. PMID: 25677121 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,757 results

Search Page

Filters